1. Home
  2. OSPN vs HQL Comparison

OSPN vs HQL Comparison

Compare OSPN & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneSpan Inc.

OSPN

OneSpan Inc.

HOLD

Current Price

$12.33

Market Cap

576.4M

Sector

Technology

ML Signal

HOLD

Logo abrdn Life Sciences Investors Shares of Beneficial Interest

HQL

abrdn Life Sciences Investors Shares of Beneficial Interest

HOLD

Current Price

$17.19

Market Cap

510.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSPN
HQL
Founded
1991
1992
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Investment Managers
Sector
Technology
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
576.4M
510.2M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
OSPN
HQL
Price
$12.33
$17.19
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$17.00
N/A
AVG Volume (30 Days)
591.9K
120.9K
Earning Date
10-30-2025
01-01-0001
Dividend Yield
3.90%
11.56%
EPS Growth
99.92
N/A
EPS
1.49
0.79
Revenue
$241,436,000.00
N/A
Revenue This Year
$1.91
N/A
Revenue Next Year
$3.49
N/A
P/E Ratio
$8.27
$17.08
Revenue Growth
N/A
N/A
52 Week Low
$11.00
$11.34
52 Week High
$20.37
$14.37

Technical Indicators

Market Signals
Indicator
OSPN
HQL
Relative Strength Index (RSI) 41.52 54.66
Support Level $12.05 $16.86
Resistance Level $12.55 $17.70
Average True Range (ATR) 0.36 0.39
MACD 0.14 -0.04
Stochastic Oscillator 59.67 62.22

Price Performance

Historical Comparison
OSPN
HQL

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.

About HQL abrdn Life Sciences Investors Shares of Beneficial Interest

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.

Share on Social Networks: